Selecting tyrosine kinase inhibitors for gastrointestinal stromal tumor with secondary KIT activation-loop domain mutations
about
UK clinical practice guidelines for the management of gastrointestinal stromal tumours (GIST).Sequencing and G-quadruplex folding of the canine proto-oncogene KIT promoter region: might dog be used as a model for human disease?Multiple target drug cocktail design for attacking the core network markers of four cancers using ligand-based and structure-based virtual screening methods.Nilotinib versus imatinib as first-line therapy for patients with unresectable or metastatic gastrointestinal stromal tumours (ENESTg1): a randomised phase 3 trial.Inactivity of imatinib in gastrointestinal stromal tumors (GISTs) harboring a KIT activation-loop domain mutation (exon 17 mutation pN822K)The Challenges of Modeling Drug Resistance to Antiangiogenic Therapy.Association of Dasatinib With Progression-Free Survival Among Patients With Advanced Gastrointestinal Stromal Tumors Resistant to Imatinib.Establishment of a GIST-T1 gastrointestinal stromal tumour cell line resistant to imatinib mesylate.BPR1J373, a novel multitargeted kinase inhibitor, effectively suppresses the growth of gastrointestinal stromal tumor
P2860
Q33612778-2BAB26DE-A91A-4A0D-B35E-B6D47D31D9D4Q35217229-7E30E9DF-5087-498B-9CC0-AD7F52647F08Q35872435-CD8FDC90-8397-4B76-9962-DC4DDE383F9AQ35905878-6E3D5891-7F9A-4E8E-8C22-6EBB2417D755Q35994305-0DBF8656-EBA1-46A0-9AC3-CB476E988D22Q44456046-555EE296-5C6A-42CB-9494-EDF37BC9809FQ54113454-D6B00DF8-B24D-4206-B79B-98C32BCAEC45Q54996923-0DF65528-3188-41EF-B28A-7E70CCA772C2Q58702370-987AAFD3-DD17-4732-BB9E-E666189AE55C
P2860
Selecting tyrosine kinase inhibitors for gastrointestinal stromal tumor with secondary KIT activation-loop domain mutations
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Selecting tyrosine kinase inhi ...... tivation-loop domain mutations
@ast
Selecting tyrosine kinase inhi ...... tivation-loop domain mutations
@en
Selecting tyrosine kinase inhi ...... tivation-loop domain mutations
@nl
type
label
Selecting tyrosine kinase inhi ...... tivation-loop domain mutations
@ast
Selecting tyrosine kinase inhi ...... tivation-loop domain mutations
@en
Selecting tyrosine kinase inhi ...... tivation-loop domain mutations
@nl
prefLabel
Selecting tyrosine kinase inhi ...... tivation-loop domain mutations
@ast
Selecting tyrosine kinase inhi ...... tivation-loop domain mutations
@en
Selecting tyrosine kinase inhi ...... tivation-loop domain mutations
@nl
P2093
P2860
P1433
P1476
Selecting tyrosine kinase inhi ...... tivation-loop domain mutations
@en
P2093
Chien-Feng Li
Chih-Lung Lin
Ching-Huai Ko
Chueh-Chuan Yen
Li-Tzong Chen
Ling-Mei Wang
Nai-Jung Chiang
Neng-Yao Shih
Ting-Shou Chen
Yan-Shen Shan
P2860
P304
P356
10.1371/JOURNAL.PONE.0065762
P407
P577
2013-06-20T00:00:00Z